Financial giants have made a conspicuous bearish move on Moderna. Our analysis of options history for Moderna MRNA revealed 28 unusual trades.
Delving into the details, we found 17% of traders were bullish, while 64% showed bearish tendencies. Out of all the trades we spotted, 24 were puts, with a value of $2,768,045, and 4 were calls, valued at $229,686.
Projected Price Targets
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $25.0 to $100.0 for Moderna over the recent three months.
Analyzing Volume & Open Interest
In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1878.47 with a total volume of 6,225.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Moderna's big money trades within a strike price range of $25.0 to $100.0 over the last 30 days.
Moderna 30-Day Option Volume & Interest Snapshot
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRNA | PUT | SWEEP | BEARISH | 01/15/27 | $52.05 | $51.8 | $52.0 | $85.00 | $847.6K | 22 | 178 |
| MRNA | PUT | TRADE | BULLISH | 04/17/25 | $5.4 | $5.35 | $5.35 | $35.00 | $535.0K | 2.2K | 1.2K |
| MRNA | PUT | TRADE | BEARISH | 12/18/26 | $42.15 | $41.5 | $42.15 | $75.00 | $316.1K | 233 | 25 |
| MRNA | PUT | TRADE | BEARISH | 12/18/26 | $42.35 | $41.0 | $42.35 | $75.00 | $105.8K | 233 | 0 |
| MRNA | PUT | TRADE | BEARISH | 01/16/26 | $12.6 | $12.4 | $12.6 | $40.00 | $99.5K | 4.0K | 79 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
In light of the recent options history for Moderna, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Where Is Moderna Standing Right Now?
- Currently trading with a volume of 3,601,101, the MRNA's price is up by 0.06%, now at $34.79.
- RSI readings suggest the stock is currently may be approaching oversold.
- Anticipated earnings release is in 35 days.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
